The Indian pharmaceutical market is growing at a rapid rate. This country is renowned as the “Pharmacy of the World” and is the global backbone of the generic drug supply.
The Indian pharmaceutical sector is the 3rd largest in the world by volume and holds the eleventh position by value. This sector comprises over 3,000 companies and 10,500 manufacturing facilities.
Companies like Theon Pharmaceuticals are part of this progress. But how is the tablet manufacturing company contributing to India’s expanding pharmaceutical manufacturing landscape?
Let’s take a closer look.
1. Strengthening Pharmaceutical Manufacturing Infrastructure
The demand for medicines is increasing day by day. In this scenario, the pharmaceutical manufacturing industry is playing a crucial role.
Theon Pharmaceuticals operates a well-developed manufacturing facility in Nalagarh, Himachal Pradesh.
The facility has dedicated production blocks for general formulations, beta-lactam products, cephalosporins and dry powder injectables. This arrangement supports specialised manufacturing processes and helps maintain appropriate production conditions.
The company’s installed annual manufacturing capacity includes:
| Pharmaceutical formulation | Annual installed capacity |
| Tablets | 2,000 million |
| Capsules | 1,000 million |
| Dry syrups | 50 million |
| Dry powder injectables | 100 million |
2. Maintaining Quality and Regulatory Standards
In pharmaceutical manufacturing, quality assurance plays an important role. Medicines need to fulfil certain guidelines and quality standards to ensure safety, consistency and efficacy.
Theon Pharmaceuticals follows current Good Manufacturing Practices (cGMP) and maintains a quality management system aligned with ISO 9001:2015 requirements.
Its quality control processes include chemical and microbiological testing. These checks help monitor product quality from raw material evaluation to finished product testing.
The company also holds facility approvals from several international regulatory authorities. These include regulatory organisations in Kenya, Tanzania, Ethiopia, Uganda, and Sri Lanka.
These approvals reflect the significance of maintaining manufacturing standards that meet the requirements of different pharmaceutical markets.
3. Supporting Drug Development Through Research and Development
In the healthcare industry, existing formulations keep changing as per the guidelines. This makes research and development an important part, which helps address the changes.
With in-depth research, pharmaceutical companies develop products with more advanced and better formulations.
Theon Pharmaceuticals established its in-house R&D centre in 2016. The facility focuses on developing cost-effective and reliable pharmaceutical formulations.
Its research activities cover several areas:
| R&D area | Key focus |
| Formulation development | Developing new pharmaceutical dosage forms |
| Modified-release technology | Developing controlled drug release formulations |
| Solubility enhancement | Improving drug solubility and bioavailability |
| Stability studies | Evaluating product stability under different conditions |
| Process validation | Supporting consistent manufacturing processes |
| Analytical development | Developing methods for product testing |
With a dedicated team and specialised research professionals, this company ensures that the product development stage meets all the right quality specifications.
The R&D team also works with manufacturing and regulatory departments during scale-up and technology transfer. This helps move developed formulations towards commercial production.
4. Expanding India’s Global Pharmaceutical Presence
The Indian pharmaceutical market expanded from USD 68.38 billion in 2025 to USD 75.89 billion in 2026 and is anticipated to grow to USD 174.67 billion by 2034, with a compound annual growth rate (CAGR) of 10.98% during the period from 2026 to 2034.
India has established itself as a strong and growing supplier of affordable generic medicines. The rising demand of these medicines internationally has also created opportunities for Indian pharmaceutical manufacturers to expand in new markets.
Theon Pharmaceuticals serves various international markets, including:
- Africa
- Southeast Asia
- Central Asia
- Latin America
- Middle East
This pharmaceutical manufacturing company aims to expand its international consumer base while meeting local pharmaceutical regulatory requirements. Its dedicated export regulatory team works on:
- Certificate of Pharmaceutical Products (COPP)
- Common Technical Document (CTD) dossiers
These activities support regulatory submissions and facilitate pharmaceutical exports.
5. Developing Specialised Manufacturing Capabilities
The pharmaceutical industry is seeing growing demand for specialised formulations, particularly sterile injectables and ophthalmic products.
In October 2024, Theon Pharmaceuticals announced the launch of a new manufacturing facility specialising in injectable and ophthalmic formulations for regulated markets.
Its dry powder injectable manufacturing capabilities include products from the cephalosporin, carbapenem and penicillin categories.
The facility uses specialised systems for vial washing, sterilisation, depyrogenation, filling, and sealing. Critical manufacturing operations are supported by Grade A cleanroom environments and Restricted Access Barrier Systems (RABS).
This investment also reflects the growing importance of specialised pharmaceutical production in India’s manufacturing sector.
6. Contributing to Affordable Healthcare
Access to safe and affordable medicines remains an important healthcare priority. Pharmaceutical manufacturers have an important role in making essential treatments available to a wider population.
Theon Pharmaceuticals focuses on developing and manufacturing formulations across different pharmaceutical categories. Its portfolio includes general medicines, beta-lactam products, cephalosporins and dry powder injectables.
The company also emphasises cost-effective formulation development and consistent product quality.
By combining manufacturing capabilities with research and quality assurance, Theon supports the broader objective of making reliable pharmaceutical products accessible across different healthcare markets.
Final Thought!
The Indian pharmaceutical industry is growing at a faster rate, and the main reason behind its growth is constant advancements in manufacturing technology and increased investment in research.
Theon Pharmaceuticals, as a trusted Pharmaceutical manufacturing company, is making a contribution to India’s growing pharmaceutical manufacturing industry with its dedicated human resources, research and development units, and advanced manufacturing infrastructure.
The constant changes in healthcare requirements make manufacturers not only stay updated to the instructions. But they also need to focus on specialised dosage forms, product quality, and innovations.
Image by https://www.theonpharma.com/
